Last reviewed · How we verify

Sham Irradiation and anti-VEGF

University of California, Davis · Phase 1 active Small molecule Quality 15/100

Sham Irradiation and anti-VEGF is a Small molecule drug developed by University of California, Davis. It is currently in Phase 1 development. Also known as: Sham proton beam + anti-VEGF.

At a glance

Generic nameSham Irradiation and anti-VEGF
Also known asSham proton beam + anti-VEGF
SponsorUniversity of California, Davis
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sham Irradiation and anti-VEGF

What is Sham Irradiation and anti-VEGF?

Sham Irradiation and anti-VEGF is a Small molecule drug developed by University of California, Davis.

Who makes Sham Irradiation and anti-VEGF?

Sham Irradiation and anti-VEGF is developed by University of California, Davis (see full University of California, Davis pipeline at /company/university-of-california-davis).

Is Sham Irradiation and anti-VEGF also known as anything else?

Sham Irradiation and anti-VEGF is also known as Sham proton beam + anti-VEGF.

What development phase is Sham Irradiation and anti-VEGF in?

Sham Irradiation and anti-VEGF is in Phase 1.

What are the side effects of Sham Irradiation and anti-VEGF?

Common side effects of Sham Irradiation and anti-VEGF include Fatigue, Hemoglobin decreased, Lymphopenia, Nausea, Alanine aminotransferase increased, Hyperglycemia.

Related